Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix change

Journal of the American College of Cardiology

Volumn 36, Issue 6, 2000, Pages 1979-1984

  Kishimoto, Chiharu ^a,b   Takamatsu, Nami ^a   Kawamata, Hiroshi ^a   Shinohara, Hiromichi ^a   Ochiai, Hiroshi ^a  

^a TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CATECHOLAMINE; CYTOKINE; FIBRIN; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE RELEASE; CONTROLLED STUDY; COXSACKIE VIRUS B3; CYTOKINE RELEASE; ENCEPHALOMYOCARDITIS VIRUS; EXTRACELLULAR MATRIX; FIBRIN DEPOSITION; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HEART VENTRICLE REMODELING; INOCULATION; MALE; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; VERO CELL; VIRUS TITRATION;

ANIMALS; CARDIOVIRUS INFECTIONS; ENCEPHALOMYOCARDITIS VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPINEPHRINE; EXTRACELLULAR MATRIX; IMMUNOGLOBULINS, INTRAVENOUS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; MALE; MICE; MICE, INBRED DBA; MYOCARDIUM; NECROSIS; NOREPINEPHRINE; RANDOM ALLOCATION;

EID: 0034669253     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00978-5     Document Type: Article

References (29)

1. Immunomodulatory effect of immunoglobulins
2. Putative mechanisms of the effect of intravenous γ-globulin
3. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome
4. Treatment of systemic vasculitis with pooled intravenous immunoglobulin
5. Treatment of refractory immune thrombocytopenic purpura with an anti-Fc-receptor antibody
6. Susceptibility to myocarditis is dependent on the response of α β T lymphocytes to coxsackieviral infection
7. Generation of humanized mice susceptible to peptide-induced inflammatory heart disease
8. Task force on the definition and classification of cardiomyopathis
9. Colocalization of myocardial fibrosis and inflammatory cells in rats
10. Extracellular matrix remodeling after coxsackievirus B3-induced murine myocarditis
11. Cell junctions, cell adhesion, and the extracellular matrix
12. Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects
13. Immunomodulation of encephalomyocarditis virus-induced disease in A/J mice
14. Captopril suppresses interstitial fibrin deposition in coxsackievirus B3 myocarditis
15. γ-Globulin treatment of acute myocarditis in the pediatric population
16. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy
17. Intravenous immune globulin in the therapy of peripartum cardiomyopathy
18. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy
19. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis
20. Autoimmune myocarditis does not require B cells for antigen presentation
21. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage, but enhanced the condition in the subsequent stage
22. Interleukin 1 and tumor necrosis factor inhibit cardiac β-adrenergic responsiveness
23. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis
24. Myocardial fibrin deposition in experimental viral myocarditis that progresses to dilated cardiomyopathy
25. Tumors: Wounds that do not heal - Similarities between tumor stroma generation and wound healing
26. Cardiac noradrenergic nerve terminal abnormalities in days with experimental congestive heart failure
27. Suppression of cytokine dependent human T-cell proliferation by intravenous immunoglobulin
28. Post-transcriptional regulation of T-cell IL-2 production by human pooled immunoglobulin
29. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: Assessments based on controlled treatment trials in patients with neurological diseases